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PREVENTION OF CATHETER ASSOCIATED URINARY TRACT INFECTION
(CAUTI) THROUGH BUNDLE OF CARE APPROACH
Patricia Ching, Principal Nurse. WHO Collaborating Centre on Infectious
Disease Epidemiology and Control, The University of Hong Kong, Hong Kong
Special Administrative Region, China
Health careeassociated catheter associated urinary tract infection (CAUTI) is
an important cause of morbidity and excess health care costs in hospitals. A
“bundle” approach is implementing a set of evidence-based practices
generally meant to be implemented together would result in significant
improvement in healthcare setting. The CAUTI bundle includes “insertion
bundle” and “maintenance bundle”. Elements in “insertion bundle” are: use
aseptic technique for insertion, avoid unnecessary catheterization. The
“maintenance bundle” includes: maintain a closed drainage system, maintain
hygiene, keep bag below level of bladder, maintain unobstructed flow,
remove catheter when no longer needed and secure catheter. Bundle
approach is proven to be effectively reducing the CAUTI rate though adopting
the quality improvement approach withmultidisciplinary team approach. The
program should also include accurate process measures of hand hygiene
compliance and bundle compliance as well as outcome measures of CAUTI
rate and appropriate indication of catheter use. Feedback to staff on the
performance measure also would increase the awareness in CAUTI preven-
tion; encourage staff to pursue for best practice and patient safety.
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REDUCING THE RISK OF TUBERCULOSIS TRANSMISSIONSP 23-1
THE PREVALENCE AND INCIDENCE OF LATENT TUBERCULOSIS INFECTION
AND ITS ASSOCIATED FACTORS AMONG VILLAGE DOCTORS IN CHINA
Guangxue He. Chinese Center for Disease Control and Prevention, Beijing,
No.155 Changbai Road, Changping District, Beijing 102206, China
Background: China is a high tuberculosis (TB) burden country. More than half
of acute TB cases first seek medical care in village doctors’ clinics or commu-
nity health centers. Despite being responsible for patient referral and man-
agement, village doctors are not systematically evaluated for TB infection or
disease. We assessed prevalence and incidence of latent TB infection (LTBI)
among village doctors in China.
Methods and Findings: A longitudinal study was conducted in Inner Mongolia
Autonomous Region. We administered a questionnaire on demographics and
risk factors for TB exposure and disease; Tuberculin skin testing (TST) and
QuantiFERON-TB Gold in-tube assay (QFT-GIT) was conducted at baseline
and repeated 12 months later. We used a logistic regression model to calcu-
late adjusted odds ratios (ORs) for risk factors for TST and QFT-GIT preva-
lence and incidence. At the time of follow up, 19.5% of the 880
participating village doctors had a positive TST and 46.0% had a positive
QFT-GIT result. Factors associated with TST prevalence included having a
BCG scar (ORZ1.45, 95%CI 1.03e2.04) and smoking (OR Z 1.69, 95%CI
1.17e2.44). Risk factors associated with QFT-GIT prevalence included being
male (OR Z 2.17, 95%CI 1.63e2.89), below college education (OR Z 1.42,
95%CI 1.01e1.97), and working for 25 years as a village doctor
(OR Z 1.64, 95%CI 1.12e2.39). The annual incidence of LTBI was 11.4% by
TST and 19.1% by QFT-GIT. QFT-GIT conversion was associated with spending
15 minutes or more per patient on average (OR Z 2.62, 95%CI 1.39e4.97)
and having BCG scar (OR Z 0.53, 95%CI 0.28e1.00).
Conclusions: Prevalence and incidence of LTBI among Chinese village doc-
tors is high. TB infection control measures should be strengthened among
village doctors and at village healthcare settings.SP 23-2
TUBERCULOSIS CONTACT INVESTIGATIONS AMONG HEALTHCARE
WORKERS
Pei-Chun Chan a,b,c,*, Yu-Hsun Huang a, Ching-Han Liu a, Wan-Ting Hsieh a,
Po-Wei Chu a, Hsiang-Lin Yang d, Chien-Ban Hsu a. aDivision of HIV/AIDS and
TB, Centers for Disease Control, Taipei, Taiwan; bInstitute of Epidemiology
and Preventive Medicine, College of Public Health, National Taiwan
University, Taipei, Taiwan; cDepartment of Pediatrics, National TaiwanUniversity Hospital, National Taiwan University, College of Medicine,
Taipei, Taiwan; dEpidemioloy Intellegence Center, Centers for Disease
Control, Taipei, Taiwan
In health care settings, tuberculosis outbreaks are notorious both in
communities with low and high TB prevalence. For those with high
prevalence of TB, TB outbreaks in health care settings could lead to
mortality among health care workers, like the tragedy happened in multi-
drug resistance TB (MDR-TB) outbreak in Church of Scotland Hospital, Tugela
Ferry, KwaZulu-Natal Province, South Africa back to 2006. For those with
low prevalence of TB, TB outbreaks in health care settings could be
controlled to the smaller extent with the strategy of contact investigation
and preventive therapy, etc. However, zero is still a target, not the reality,
if without effective vaccine to prevent infections breaking into active
diseases.
A matured and well-organized TB control program should always include a
comprehensive contact investigation protocol for every contagious TB index
patient. Health care settings should definitely not to be excluded. However,
contact investigation itself is time and resource consuming, which leads to
unsatisfactory condition of public health control measure among health care
workers, when he/she become a TB contact. Here we will provide some
examples for audience to understand how the investigations are carried on
in health care settings at frontline. We’ll also share the obstacles for
infection control we observe and how we face the challenges to support
occupational health among healthcare workers in Taiwan.
Without doubt, health care workers are persistently facing higher risk of TB
compared to the age-stratified general populations. How we could improve
the occupational health with busy daily medical practice? How we could
deliver the concept that the protection of employee’s health leads to better
patient safety and more efficient utilization of human resources? That would
be a very important part of post-2015 global TB control strategies.
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PRINCIPLES OF MDR-TB CONTROL
Chen-Yuan Chiang. International Union Against Tuberculosis and Lung
Disease (The Union), Paris France; Division of Pulmonary Medicine,
Department of Internal Medicine, Wan Fang Hospital, Taipei Medical
University, Taiwan
World Health Organization estimated that globally, 3.6% (95% CI:
2.1e5.1%) of new TB cases and 20.2% (95%CI: 13.3e27.2%) of previously
treated cases have multidrug-resistant tuberculosis (MDR-TB). On average,
an estimated 9.6% (95% CI: 8.1%e11%) of MDR-TB cases have extensively
drug-resistant tuberculosis (XDR-TB). The estimated number of incident
MDR-TB cases globally in 2012 was 450 000 (range: 300 000e600 000), and
that among patients with pulmonary TB notified in 2012 was 300 000
(range: 220 000e380 000). The burden of MDR-TB is high in South East Asia
and Western Pacific Regions, especially in India, China, the Philippines,
Indonesia, Myanmar, and Bangladesh. The proportion of TB cases with drug
susceptibility testing (DST) for first line anti-tuberculosis drugs was low in
South East Asia and Western Pacific Regions. In 2012, the proportion of
retreatment TB cases with DST result was 7% in Bangladesh, 12% in China,
10% in Indonesia, 9% in the Philippines. Globally, 83 715 cases of MDR-TB
were notified to WHO in 2012, represented 28% of the 300 000 pulmonary
TB patients estimated to have MDR-TB in 2012. Outcome of MDR-TB was
disappointedly low in both South East Asia and Western Pacific Regions. In
both regions, the proportion of MDR-TB patients in the 2010 cohort who
successfully completed treatment was <50%, while about 30% of cases
were reported as lost to follow-up or had no outcome information.
Intensified regional and national efforts to detect cases of MDR-TB and
to improve treatment outcomes are urgently required. Stringent infection
control to prevent transmission of MDR-TB in health care facilities must be
implemented.
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RELEVANCE OF LATENT TB INFECTION IN AREAS OF HIGH TB
PREVALENCE
Cynthia Bin-Eng Chee. TB Control Unit, Tan Tock Seng Hospital,
Singapore
The Global TB Strategy after 2015 (“The End TB Strategy”) endorsed by the
World Health Assembly in May 2014 sets an ambitious target of 90% reduction
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this strategy is integrated, patient-centred care and prevention, of which a
key component is the preventive treatment of persons at high risk of
tuberculosis.
Latent TB infection (LTBI) is an asymptomatic state identified by a positive
tuberculin skin test (TST) or interferon-gamma release (IGRA) result
(indicating immunosensitization to Mycobacterium tuberculosis antigen) in
the absence of clinical and chest radiological evidence of TB disease. Per-
sons with LTBI have a 10% lifetime risk of developing active TB. The high
risk period for developing active TB is within the first few years after initial
infection. The risk of developing active disease is also heavily dependent on
the host immunological status.
Preventive therapy (PT) with isoniazid has an efficacy of 60-90% in reducing
the development of active disease. Isoniazid hepatotoxicity rates have been
reported as 0.1% to 1%. Thus LTBI screening should be targeted at selected
high risk groups for whom the benefit of PT would outweigh the risk of drug
toxicity; and in whom adherence to and completion of PT is likely to be high.
Routine PT for persons living with HIV and for childhood contacts below 5
years of age has been recommended by the World Health Organization
(WHO) for several years. In late 2014, WHO published Guidelines for high /
upper middle-income countries with TB incidence rate < 100 / 100,000
population. These Guidelines recommend the systematic screening and
treatment of LTBI in people living with HIV, adult and child contacts of
pulmonary TB cases, patients initiating anti-TNF treatment, patients
receiving dialysis, patients preparing for organ or haematologic transplan-
tation and patients with silicosis.
Singapore, an intermediate TB incidence country with mass BCG vaccination
at birth, has performed LTBI screening of close contacts of infectious
pulmonary TB cases for PT since 1998. Our experience with this TB control
strategy will be presented.SYMPOSIUM 24 (SP 24)
CONTROL OF MDRO IN THE HOSPITALSSP 24-1
EPIDEMIOLOGY: ASIA VS. EUROPE
Giuseppe Cornaglia *, Alda Bazaj. Department of Pathology and Diagnostics,
University of Verona, Italy
Multi-drug-resistant organisms (MDRO) are still on the surge in virtually all
geographical areas, in spite of curbing antibiotic consumptions and of the
partial success of containment campaigns.
Emergence of new resistance determinants, with special reference to beta-
lactamases, genetic association of different resistance mechanisms, and
spread of MDR clones all account for this enduring threat to Public Health.
Although antimicrobial resistance is generally very high, prevalence of
various MDRO is different between Europe and Asia, as for both absolute
figures and resistance determinants. A good example is given by the
prevalence of different types of carbapenemases, some of which had their
first description in either Continent.
It must be underlined that, in both Continents, ’Continental’ rates are
almost invariably mere artifacts, since inter-State variability can be surpris-
ingly high.SP 24-2
CONTROLLING VRE USING TECHNOLOGY
Dale Fisher. National University Hospital System (NUHS), Singapore
Vancomycin-resistant enterococci (VRE) emerged at our hospital in the mid-
2000s. Despite implementing targeted active surveillance in 2006 with strict
single room isolation and contact precautions for those identified, theprevalence of VRE continued to rise. Further interventions were introduced
in late-2012 / early-2013 to effectively create a VRE Bundle.
This bundle comprised a number of efforts including 2 specific technologic
innovations, hydrogen peroxide terminal cleaning and an automated
electronic alert system to identify known VRE carriers at the time of
admission. In addition manual cleaning audits were enhanced, precautions
signage modified, and the manual cleaning solution changed. A ‘breakpoint’
regression model was fitted to the monthly number of VRE cases from
January 2008 to January 2014 to evaluate potentially differing trends before
and after each intervention.
A total of 341 cases were reported over this 73 month period. Sixty-five
percent of cases were identified after 48 hours of hospitalization, suggesting
hospital transmission. Sixty-three percent of cases were clinical cultures,
22% were from contact tracing, and 15% from active surveillance. The best
estimate for the breakpoint corresponds to early February 2013 (95%
confidence interval, CI: August 2012dJune 2013), when the bundle was
implemented. The peak incidence was 9.2 cases per month (95% CI:
6.0d13.2) in March 2013 and reduced to 2.4 case per month (95%
CI:1.1d4.7) by January 2014.
Conclusions: The bundle of interventions was associated with a significant
change in the incidence of VRE at our hospital. Confidence intervals around
the breakpoint suggested that all elements of the bundle (apart from the
change in bleach cleaning solution) could have played a role in the reduction
of VRE.SP 24-3
CONTROLLING THE HEALTHCARE-ASSOCIATED SPREAD OF
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
David K. Henderson. NIH Clinical Center, United States
This presentation addresses the burgeoning problem of antimicrobial
resistance, first attempting to place the current situation in historical
perspective, secondly underscoring the fact that we are faced currently
with several specific multiply-resistant pathogens, including Methicillin-
resistant Staphylococcus aureus, Vancoycin-resistant enterococci, and
Clostridium difficile, among others. The discussion will then focus on the
speicif problems relating to the control of Carbapenem-Resistant Entero-
bacteriaceae (CRE) in healthcare. The presentation next discusses preven-
tion interventions in historical perspective, noting the challenges
associated with the “Semmelweis Effect” and attempts to induce cultural
change. The presentation next focuses on specific MDRO outbreaks that
have occurred at the Clinical Center at the National Institutes of Health,
emphasizing the interventions employed and discussing the practical appli-
cation of whole genome sequencing to issues of relevance to healthcare
epidemiology.SP 24-4
STEWARDSHIP STRATEGIES TO CONTROL MDRO
Ursula Theuretzbacher. Center for Anti-Infective Agents, Vienna, Austria
Antimicrobial stewardship (AMS) programs aim at ensuring appropriate and
responsible use of antimicrobial drugs in order to provide optimized
treatment outcome including a reduced risk of adverse effects and
minimized risk of emergence of resistance while promoting cost-effective-
ness. In addition to the immediate effects on individual patients and health
care systems the aspect of preserving the power of antimicrobial drugs as
vital resources for future generations gains momentum. AMS is recognized as
a key component in addressing the global challenge of increasing antimi-
crobial resistance. Global strategies are needed to define “responsible use”
of antibiotics and create a global framework for AMS strategies to control
the selection pressure on pathogens. International initiatives such as DRIVE-
AB and stewardship strategies are discussed to preserve the activities of
antibiotics in an era of limited supply of new drugs.
